To the full analysis
Fortive stock: growth
FTVFortive reported $5.14B in revenue for fiscal 2025, down 17.5% on the prior year, up 2.1% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
−0.9%
per year from 2012 to 2025, per share −0.2%
Earnings (Annual rate)
−2.1%
per year from 2012 to 2025, per share −1.8%
Free cash flow (Annual rate)
0.9%
per year from 2012 to 2025, per share 1.5%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2012 | |
|---|---|---|---|
| Revenue | 2.1% | −1.8% | −0.9% |
| Revenue per share | 3.4% | −1.0% | −0.2% |
| Earnings | −18.5% | −3.9% | −2.1% |
| Earnings per share | −17.5% | −3.5% | −1.8% |
| Free cash flow | −6.4% | 1.0% | 0.9% |
| Free cash flow per share | −5.2% | 1.8% | 1.5% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2012 | $5.79B | $763.7M | $874.4M |
| 2013 | $5.96B | $830.9M | $949.1M |
| 2014 | $6.34B | $883.4M | $844.1M |
| 2015 | $6.18B | $863.8M | $888.9M |
| 2016 | $6.22B | $872.3M | $1.01B |
| 2017 | $5.76B | $1.04B | $1.04B |
| 2018 | $6.45B | $2.91B | $1.23B |
| 2019 | $4.56B | $738.9M | $1.16B |
| 2020 | $4.63B | $1.61B | $1.36B |
| 2021 | $5.25B | $608.4M | $911.1M |
| 2022 | $5.83B | $755.2M | $1.21B |
| 2023 | $6.07B | $865.8M | $1.25B |
| 2024 | $6.23B | $832.9M | $1.41B |
| 2025 | $5.14B | $579.2M | $978.1M |
Revenue by segment
How Fortive Corporation makes its money and how that has shifted. Names are as the company reports them.
- Intelligent Operating Solutions$2.9B56%
- Advanced Healthcare Solutions$1.3B25%
- Other$983.5M19%
“Other” combines smaller and former segments with revenue the company does not assign to a segment. Names as reported, with abbreviations spelled out for the largest companies. The company split earlier years differently. A history would not be comparable, so only 2025 is shown.
Figures as a table
| 2025 | Share 2025 | |
|---|---|---|
| Intelligent Operating Solutions | $2.86B | 55.5% |
| Advanced Healthcare Solutions | $1.3B | 25.3% |
| Other | $983.5M | 19.1% |
| Total revenue | $5.14B | 100% |
Revenue by region
Where Fortive Corporation generates its revenue.
- United States54%
- Countries Excluding United States and China35%
- China10%
Figures as a table
| 2020 | 2021 | 2022 | 2023 | 2024 | Share 2024 | |
|---|---|---|---|---|---|---|
| United States | $2.44B | $2.68B | $3.14B | $3.29B | $3.37B | 54.1% |
| Countries Excluding United States and China | $1.66B | $1.92B | $1.99B | $2.08B | $2.21B | 35.5% |
| China | $534.1M | $650.7M | $702.1M | $694.9M | $648.2M | 10.4% |
| Total revenue | $4.63B | $5.25B | $5.83B | $6.07B | $6.23B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 31 Jul 2022)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.